BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Metabolism of nitric oxide
,
Tamoxifen
,
rs2300478
,
PRKCA
,
cell-cell adhesion
,
Ischemia
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
sites tumour
Summary
General Info
Curated Studies
Most Correlated Studies
Common activation of RAS_MAPK pathway in serous LMP tumours
Gastrointestinal stromal tumours with KIT or PDGFRA mutation
Lymphatic endothelium of metastatic tumours has a distinct transcription profile.
EORTC 10994 clinical trial: Identification of molecular apocrine breast tumours
BRD7 is a candidate tumour suppressor gene required for p53 function
Explore Curated Studies Results
Literature
Most Relevant Literature
Adaptive immune resistance at the tumour site: mechanisms and therapeutic opportunities.
Tumor Site-Specific Cleavage Improves the Antitumor Efficacy of Antibody-Drug Conjugates.
Differential profile of protumor immunological factors between the tumor site and the tumor-free sit…
Human T lymphocytes at tumor sites.
Efficacy and Safety of Gastrointestinal Tumour Site Marking with da Vinci-Compatible Near-Infrared F…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Predicting Sites of Tumour Progression in the Invasive Margin of Glioblastomas (PRaM-GBM Study)
Postoperative Identification of Tumor Cells at the Lumpectomy Site of Patients With Early Breast Can…
Magnetic Resonance Imaging-guided Thermal Radiofrequencey Ablation of Primary Renal Cell Carcinoma, …
Tumor and Vaccine Site With a Toll Like Receptor (TLR) Agonist
Hypofractionated Radiation by CyberKnife as a Mean of the Tumor Site's Radiation After Conventional …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ